Innosys Co Ltd
KOSDAQ:056090
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innosys Co Ltd
KOSDAQ:056090
|
KR |
Intrinsic Value
The intrinsic value of Innosys Co Ltd (056090) under the Base Case is 11 580.3 KRW per share. Compared with the current market price of 4 550 KRW, the stock appears Undervalued by 61% .
The intrinsic value is calculated using the DCF method. The model assumes net margin rises from 14% last year to 18% by 2031, higher than in any of the last six years. Revenue grows about 34% in 2026, then slows: about 21% a year on average over the next five years, about twice its five-year pace of 11%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Innosys Does
Innosys Co. Ltd. engages in the manufacture of orthopaedic surgical implants and surgical devices. The company is headquartered in Uijeongbu, Gyeonggi-Do. The company went IPO on 2015-11-12. The firm operates its business through two segments. The Medical Device Business segment is engaged in the manufacture and sale of spinal fixation devices, micro-invasive medical devices for the treatment of back pain, fracture treatment devices, bioabsorbable alloy implants and other products.
- Headquarters
- Korea KR
- IPO date
- Nov 12, 2015
Revenue & Expenses Breakdown
Innosys Co Ltd
Earnings Waterfall
Innosys Co Ltd
The intrinsic value for Innosys Co Ltd (056090) under the Base Case is 11 580.3 KRW.
Compared with the current market price of 4 550 KRW, the stock appears Undervalued by 61% .